Skip to main content

Table 1 Baseline characteristics between the groups according to nonalcoholic fatty liver disease and abdominal obesity status

From: Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study

 

Total population

NAFLD (−) abdominal obesity (−)

NAFLD (−) abdominal obesity (+)

NAFLD (+) abdominal obesity (−)

NAFLD (+) abdominal obesity (+)

p

N (%)

21,335 (100)

9,052 (42.4)

2,220 (10.4)

4,859 (22.8)

5,204 (24.5)

 

Age (year)

40.8 ± 7.3

39.5 ± 6.7a

45.1 ± 9.4

39.4 ± 5.8a

42.3 ± 7.6

<0.001

SBP (mmHg)

114.9 ± 12.0

112.3 ± 11.4

116.1 ± 12.2

115.1 ± 11.5

118.8 ± 12.1

<0.001

DBP (mmHg)

74.5 ± 9.6

72.4 ± 9.0

77.7 ± 9.7

75.7 ± 9.5

76.65 ± 9.6

<0.001

FBS (mg/dL)

99.1 ± 16.8

95.9 ± 12.4

99.2 ± 14.2a

100.0 ± 18.5a

103.8 ± 21.0

<0.001

TC (mg/dL)

203.0 ± 31.2

196.2 ± 32.7

203.9 ± 34.7

206.2 ± 35.3

211.6 ± 37.0

<0.001

TG (mg/dL)

122 (87–174)

97 (72–132)

117 (87–164)

142 (104–196)

160 (117–219)

<0.001

HDL-C (mg/dL)

51.1 ± 12.0

55.6 ± 12.5

51.5 ± 11.4

48.0 ± 10.4

45.9 ± 9.6

<0.001

LDL-C (mg/dL)

131.4 ± 31.7

124.7 ± 29.6

132.6 ± 31.3

134.9 ± 31.8

139.2 ± 32.8

<0.001

AST (IU/L)

24.1 ± 13.3

21.3 ± 11.2

22.8 ± 10.8

24.5 ± 12.1

29.1 ± 16.7

<0.001

ALT (IU/L)

30.3 ± 23.7

22.1 ± 15.8

26.2 ± 19.6

33.6 ± 21.5

43.0 ± 31.3

<0.001

γ-GTP (IU/L)

30 (21–48)

23 (17–34)

31 (21–49)

33 (24–51)

43 (30–66)

<0.001

hs-CRP (mg/dL)

0.05 (0.03–0.11)

0.04 (0.02–0.07)

0.06 (0.04–0.11)a

0.06 (0.04–0.10)a

0.09 (0.05–0.16)

<0.001

HOMA-IR

1.33 (0.877–2.000)

0.982 (0.657–1.406)

1.368 (0.931–1.959)

1.506 (1.049–2.112)

2.045 (1426–2.995)

<0.001

HbA1c (%)

5.72 ± 0.55

5.60 ± 0.40

5.70 ± 0.46

5.75 ± 0.58

5.89 ± 0.70

<0.001

Waist-hip ratio

0.909 ± 0.287

0.867 ± 0.026

0.927 ± 0.026

0.882 ± 0.017

0.934 ± 0.026

<0.001

BMI (kg/m2)

24.7 ± 3.0

22.8 ± 2.1

26.0 ± 2.3

24.5 ± 1.9

27.1 ± 2.7

<0.001

Waist circumference (cm)

86.6 ± 7.9

81.6 ± 5.9

89.4 ± 6.1

86.7 ± 5.3

93.9 ± 7.1

<0.001

Lean mass (kg)

53.3 ± 5.8

52.0 ± 5.3a

52.2 ± 5.6a

54.4 ± 5.6

54.9 ± 6.1

<0.001

Fat mass (kg)

17.6 ± 6.0

13.7 ± 3.7

20.2 ± 4.7

17.0 ± 3.4

23.7 ± 5.8

<0.001

Percent body fat (%)

23.3 ± 5.3

19.7 ± 4.0

26.5 ± 3.8

22.7 ± 3.1

28.7 ± 4.0

<0.001

Proportion of subjects with diabetes (%)

1,264 (5.9)

229 (2.5)

130 (5.9)

303 (6.2)

602 (11.6)

<0.001

Proportion of subjects with hypertension (%)

2,116 (9.9)

496 (5.5)

290 (13.1)

424 (8.7)

907 (17.4)

<0.001

Proportion of subjects with statin medication (%)

767 (3.6)

171 (1.9)

102 (4.6)

205 (4.2)

289 (5.6)

<0.001

Proportion of who has ever smoked (%)

12,122 (56.8)

4,853 (53.6)

2,825 (58.2)

1,573 (58.5)

6,571 (60.4)

<0.001

Proportion of subjects with do regular exercise (%)

3,807 (17.8)

1,750 (19.3)

421 (19)

790 (16.3)

846 (16.3)

<0.001

  1. Values are expressed as mean ± standard deviation, median (interquartile range) or percentage.
  2. NAFLD nonalcoholic fatty liver disease, WHR waist-hip ratio, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FBS fasting blood glucose, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, ALT alanine aminotransferase, AST aspartate aminotransferase, HbA1c glycated hemoglobin.
  3. aNo differences between the groups with same footnotes in post hoc analyses.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840